However, our results indicated that ABCB1 rs1045642 and ABCC1 rs3743527 did not influence the development of cardiotoxicity after anthracycline-based treatment in the studied group of patients with breast cancer (Table 5). This evidence concerns the gene ABCB1 and breast carcinoma.